Morton DL - Search Results

1

Molecular characterization of inflammatory genes in sentinel and nonsentinel nodes in melanoma.

Torisu-Itakura H, Lee JH, Scheri RP, Huynh Y, Ye X, Essner R, Morton DL. Torisu-Itakura H, et al. Among authors: morton dl. Clin Cancer Res. 2007 Jun 1;13(11):3125-32. doi: 10.1158/1078-0432.CCR-06-2645. Clin Cancer Res. 2007. PMID: 17545514

2

Role of sentinel lymphadenectomy in thin invasive cutaneous melanomas.

Bleicher RJ, Essner R, Foshag LJ, Wanek LA, Morton DL. Bleicher RJ, et al. Among authors: morton dl. J Clin Oncol. 2003 Apr 1;21(7):1326-31. doi: 10.1200/JCO.2003.06.123. J Clin Oncol. 2003. PMID: 12663722

3

Factors predictive of tumor-positive nonsentinel lymph nodes after tumor-positive sentinel lymph node dissection for melanoma.

Lee JH, Essner R, Torisu-Itakura H, Wanek L, Wang H, Morton DL. Lee JH, et al. Among authors: morton dl. J Clin Oncol. 2004 Sep 15;22(18):3677-84. doi: 10.1200/JCO.2004.01.012. J Clin Oncol. 2004. PMID: 15365064

4

Quantitative analysis of melanoma-induced cytokine-mediated immunosuppression in melanoma sentinel nodes.

Lee JH, Torisu-Itakara H, Cochran AJ, Kadison A, Huynh Y, Morton DL, Essner R. Lee JH, et al. Among authors: morton dl. Clin Cancer Res. 2005 Jan 1;11(1):107-12. Clin Cancer Res. 2005. PMID: 15671534

5

Sentinel lymphadenectomy does not increase the incidence of in-transit metastases in primary melanoma.

Kang JC, Wanek LA, Essner R, Faries MB, Foshag LJ, Morton DL. Kang JC, et al. Among authors: morton dl. J Clin Oncol. 2005 Jul 20;23(21):4764-70. doi: 10.1200/JCO.2005.20.537. J Clin Oncol. 2005. PMID: 16034052

6

Melanoma recurrence patterns after negative sentinel lymphadenectomy.

Zogakis TG, Essner R, Wang HJ, Turner RR, Takasumi YT, Gaffney RL, Lee JH, Morton DL. Zogakis TG, et al. Among authors: morton dl. Arch Surg. 2005 Sep;140(9):865-71; discussion 871-2. doi: 10.1001/archsurg.140.9.865. Arch Surg. 2005. PMID: 16172295

7

Surgical management of the groin lymph nodes in melanoma in the era of sentinel lymph node dissection.

Essner R, Scheri R, Kavanagh M, Torisu-Itakura H, Wanek LA, Morton DL. Essner R, et al. Among authors: morton dl. Arch Surg. 2006 Sep;141(9):877-82; discussion 882-4. doi: 10.1001/archsurg.141.9.877. Arch Surg. 2006. PMID: 16983031

8

Natural history of melanoma in 773 patients with tumor-negative sentinel lymph nodes.

Zogakis TG, Essner R, Wang HJ, Foshag LJ, Morton DL. Zogakis TG, et al. Among authors: morton dl. Ann Surg Oncol. 2007 May;14(5):1604-11. doi: 10.1245/s10434-006-9267-6. Epub 2007 Mar 1. Ann Surg Oncol. 2007. PMID: 17333418

9

Isolated tumor cells in the sentinel node affect long-term prognosis of patients with melanoma.

Scheri RP, Essner R, Turner RR, Ye X, Morton DL. Scheri RP, et al. Among authors: morton dl. Ann Surg Oncol. 2007 Oct;14(10):2861-6. doi: 10.1245/s10434-007-9472-y. Epub 2007 Jul 18. Ann Surg Oncol. 2007. PMID: 17882497

10

Importance of sentinel lymph node biopsy in patients with thin melanoma.

Wright BE, Scheri RP, Ye X, Faries MB, Turner RR, Essner R, Morton DL. Wright BE, et al. Among authors: morton dl. Arch Surg. 2008 Sep;143(9):892-9; discussion 899-900. doi: 10.1001/archsurg.143.9.892. Arch Surg. 2008. PMID: 18794428 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

686 results

Search Page

Filters